-+ 0.00%
-+ 0.00%
-+ 0.00%

Vanda Pharmaceuticals Affirms FY2025 Sales Guidance of $210.00M-$250.00M vs $222.86M Est

Benzinga·05/07/2025 20:10:17
Listen to the news
Vanda Pharmaceuticals (NASDAQ:VNDA) affirms FY2025 sales outlook from $210.00 million-$250.00 million to $210.00 million-$250.00 million vs $222.86 million estimate.